Detalles de la búsqueda
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952217
Resultados
1 -
1
de 1
1
Próxima >
>>